SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-19-001620
Filing Date
2019-05-22
Accepted
2019-05-22 12:53:47
Documents
3
Effectiveness Date
2019-05-22

Document Format Files

Seq Description Document Type Size
1 dfan14a12274002_05222019.htm DFAN14A 24950
2 EX. 1. - LETTER TO STOCKHOLDERS, DATED MAY 22, 2019 ex1todfan14a12274002_052219.pdf DFAN14A 167736
3 GRAPHIC shareholder.jpg GRAPHIC 406019
  Complete submission text file 0000921895-19-001620.txt   817084
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Subject) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-23143 | Film No.: 19844935
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055B POWERS PLACE SUITE 810 ALPHARETTA GA 30009
Business Address 5348 VEGAS DR., UNIT 733 LAS VEGAS NV 89108 404-664-3629
Altiva Management Inc. (Filed by) CIK: 0001772491 (see all company filings)

IRS No.: 821992901 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DFAN14A